OncoSeer Diagnostics

Private

Dallas, TexasHealthcare & Life Scienceshttps://oncoseer.com/

Last Round

Seed

Nov 28, 2022

Total Funding Raised

$1M

Company Overview

OncoSeer Diagnostics is a diagnostic equipment company that develops multimarker blood tests to predict, monitor, and diagnose immune-related adverse events in oncology patients undergoing immune checkpoint inhibitor therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

immune-related adverse eventsirAEscancer immunotherapyICI therapyimmune checkpoint inhibitorbiomarker blood testprecision oncologyliquid biopsypredictive diagnosticsbioinformaticsclinical decision supportAI diagnosticsB-cell repertoireimmunotoxicitypatient safety

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoSeer Diagnostics Comps

Public and private peers based on sector, stage, and business model.

OncoSeer Diagnostics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoSeer Diagnostics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 28, 2022
Grant	Sep 1, 2020
Grant	Jul 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Jeffrey M. Stone

Co-Founder and CEO

Founding Team

OncoSeer Diagnostics Investors

Notable investors and investment history

OncoSeer Diagnostics investors
Investor	Rounds
National Institute of Allergy and Infectious Diseases	Grant
Melanoma Research Alliance	Grant
National Institutes of Health (NIH)	Grant
JMS Capital	Seed

View all Investors

OncoSeer Diagnostics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

OncoSeer Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoSeer Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas

Employee Range1

Year Founded2022

Last FundingNov 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.